Hugel becomes the first and only Korean company that have market approvals in all three major aesthetic markets – U.S., Europe and China U.S. is the largest and fastest growing aesthetic market globally at USD 2.5 bn in 2023, and expected to nearly double to USD 4.9 bn by 2031 SEOUL,…
Hugel Receives U.S. FDA Approval for Its Botulinum Toxin Letybo
This post was originally published on this site